Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C.
The authors treated a 38-year-old man with nanophthalmic uveal effusion with scleral windows and local application of mitomycin-C. The patient underwent two separate surgical procedures, involving placement of scleral windows in all four quadrants and topical application of mitomycin-C in one quadrant. Episcleral scarring led to closure of scleral windows in all quadrants except one quadrant where mitomycin-C was applied during the first surgery. The uveal effusion resolved following the second surgery. No complications related to mitomycin-C were observed. Topical mitomycin-C may be a useful adjunct in the surgical management of uveal effusion syndrome.
Akduman
L
L
Department of Ophthalmology, Washington University School of Medicine, St. Louis, MO 63110-1096, USA.
Adelberg
D A
DA
Del Priore
L V
LV
D000287:Administration, Topical; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D005122:Exudates and Transudates; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008850:Microphthalmos / Q000150:complications*; D016685:Mitomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D012590:Sclera / Q000601:surgery*; D013577:Syndrome; D014603:Uveal Diseases / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D014792:Visual Acuity
D000903:Antibiotics, Antineoplastic; D009883:Ophthalmic Solutions; D016685:Mitomycin